Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Queensland Health
Harvard Business School
Argus Health
Fuji
Merck
Daiichi Sankyo
Chinese Patent Office
Deloitte

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022066

« Back to Dashboard

NDA 022066 describes OMNISCAN, which is a drug marketed by Ge Healthcare and is included in two NDAs. It is available from one supplier. Additional details are available on the OMNISCAN profile page.

The generic ingredient in OMNISCAN is gadodiamide. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the gadodiamide profile page.
Summary for 022066
Tradename:OMNISCAN
Applicant:Ge Healthcare
Ingredient:gadodiamide
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 022066
Suppliers and Packaging for NDA: 022066
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OMNISCAN gadodiamide INJECTABLE;INJECTION 022066 NDA GE Healthcare Inc. 0407-0690 N 0407-0690-30
OMNISCAN gadodiamide INJECTABLE;INJECTION 022066 NDA GE Healthcare Inc. 0407-0690 N 0407-0690-40

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength14.35GM/50ML (287MG/ML)
Approval Date:Sep 5, 2007TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength28.7GM/100ML (287MG/ML)
Approval Date:Sep 5, 2007TE:RLD:Yes

Expired US Patents for NDA 022066

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge Healthcare OMNISCAN gadodiamide INJECTABLE;INJECTION 022066-002 Sep 5, 2007 ➤ Sign Up ➤ Sign Up
Ge Healthcare OMNISCAN gadodiamide INJECTABLE;INJECTION 022066-001 Sep 5, 2007 ➤ Sign Up ➤ Sign Up
Ge Healthcare OMNISCAN gadodiamide INJECTABLE;INJECTION 022066-002 Sep 5, 2007 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Citi
Healthtrust
UBS
AstraZeneca
Baxter
US Army
Covington
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.